4/A
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-21-028358
Options or other derivatives
- President & CEO acquired 140,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| USMAN NASSIM President & CEO | 2021-02-08 | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | D: show line 1 in the form |
Loading xslF345X03/doc4a.xml…